Report Thumbnail
Product Code IW091401844HIW
Published Date 2021/12/14
English152 PagesNorth America

NORTH AMERICA COSMETIC SURGERY AND PROCEDURE MARKET FORECAST 2022-2030Pharmaceutical_LifeSciense Market


Report Thumbnail
Product Code IW091401844HIW◆The Dec 2025 edition is also likely available. We will check with the publisher immediately.
Published Date 2021/12/14
English 152 PagesNorth America

NORTH AMERICA COSMETIC SURGERY AND PROCEDURE MARKET FORECAST 2022-2030Pharmaceutical_LifeSciense Market



Abstract


Summary

KEY FINDINGS The North America cosmetic surgery and procedure market is projected to record a CAGR of 5.53% during the forecast period of 2022 to 2030. The growing demand for surgical as well as non-surgical cosmetic procedures, the aesthetically conscious aging population, and the declining stigma associated with cosmetic surgeries are among the key factors accredited to the region’s market growth. MARKET INSIGHTS The North America cosmetic surgery and procedure market growth assessment entails the evaluation of Canada and the United States. Canada has a larger young population, with a desire to appear attractive for social reasons. The increase in user confidence, the influence of social media, the rise in popularity of facial beauty, and economic feasibility predominantly fuel the country’s demand for surgical as well as non-surgical procedures. Moreover, the younger population base is more inclined towards non-invasive procedures on account of key advantages such as reduced discomfort and a relatively minimal postoperative time. On the other hand, the elderly also opt for aesthetic manipulations. While the majority of the population across eastern nations retire at the age of 60, the retirement age in Canada is 65. This aspect leads to an additional five years of professional and social lives, thus generating the need to look young and energetic. Hence, the demand for cosmetic procedures is increasing in the country. As a result, these factors are set to boost the cosmetic surgery and procedure market in North America over the forecasted years. COMPETITIVE INSIGHTS Leading players operating in the region are Allergan PLC, Sientra Inc, Bausch Health Companies Inc, etc. Our report offerings include: • Explore key findings of the overall market • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges) • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions • Market Segmentation cater to a thorough assessment of key segments with their market estimations • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share • Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc. • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc. • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Table of Contents

  • 1 RESEARCH SCOPE & METHODOLOGY

    • 1.1 STUDY OBJECTIVES
    • 1.2 SCOPE OF STUDY
    • 1.3 METHODOLOGY
    • 1.4 ASSUMPTIONS & LIMITATIONS
  • 2 EXECUTIVE SUMMARY

    • 2.1 MARKET SIZE & ESTIMATES
    • 2.2 MARKET OVERVIEW
  • 3 MARKET DYNAMICS

    • 3.1 KEY DRIVERS
      • 3.1.1 AGING POPULATION LEADS TO AN INCREASED DEMAND FOR ANTI-AGING COSMETIC AND AESTHETIC TREATMENTS
      • 3.1.2 RAPID GROWTH OF THE AESTHETIC INDUSTRY
      • 3.1.3 PREFERENCE FOR MINIMALLY INVASIVE AND NON-INVASIVE PROCEDURES OVER INVASIVE PROCEDURES
    • 3.2 KEY RESTRAINTS
      • 3.2.1 HIGH RATE OF AESTHETIC USAGES AND IMPLANTABLE MEDICAL DEVICES
      • 3.2.2 DIFFICULTIES RELATED TO COSMETIC TREATMENT
      • 3.2.3 SAFETY CONCERNS RELATED TO BREAST IMPLANT
  • 4 KEY ANALYTICS

    • 4.1 IMPACT OF COVID-19 ON COSMETIC SURGERY AND PROCEDURE MARKET
    • 4.2 KEY MARKET TRENDS
    • 4.3 PORTER’S FIVE FORCES ANALYSIS
      • 4.3.1 BUYERS POWER
      • 4.3.2 SUPPLIERS POWER
      • 4.3.3 NEW ENTRY
      • 4.3.4 SUBSTITUTIONS
      • 4.3.5 INDUSTRY RIVALRY
    • 4.4 VALUE CHAIN ANALYSIS
    • 4.5 REGULATORY FRAMEWORK
    • 4.6 OPPORTUNITY MATRIX
    • 4.7 VENDOR LANDSCAPE
  • 5 MARKET BY TYPE

    • 5.1 SURGICAL
      • 5.1.1 BREAST AUGMENTATION
      • 5.1.2 LIPOSUCTION
        • 5.1.2.1 LASER ASSISTED LIPOSUCTION
        • 5.1.2.2 RADIO FREQUENCY ASSISTED LIPOSUCTION
        • 5.1.2.3 ULTRASOUND ASSISTED LIPOSUCTION
        • 5.1.2.4 OTHER LIPOSUCTION SURGERIES
      • 5.1.3 EYELID SURGERY
      • 5.1.4 TUMMY TUCK
      • 5.1.5 BREAST LIFT
      • 5.1.6 OTHER SURGICAL TYPES
    • 5.2 NON-SURGICAL
      • 5.2.1 BOTULINUM TOXIN
      • 5.2.2 DERMAL FILLERS
      • 5.2.3 LASER HAIR REMOVAL
      • 5.2.4 CHEMICAL PEEL
      • 5.2.5 MICRODERMABRASION
      • 5.2.6 PHOTO-REJUVENATION
      • 5.2.7 OTHER NON-SURGICAL TYPES
  • 6 GEOGRAPHICAL ANALYSIS

    • 6.1 NORTH AMERICA
      • 6.1.1 MARKET SIZE & ESTIMATES
      • 6.1.2 KEY GROWTH ENABLERS
      • 6.1.3 KEY CHALLENGES
      • 6.1.4 KEY PLAYERS
      • 6.1.5 COUNTRY ANALYSIS
        • 6.1.5.1 UNITED STATES
        • 6.1.5.2 CANADA
  • 7 COMPETITIVE LANDSCAPE

    • 7.1 KEY STRATEGIC DEVELOPMENTS
      • 7.1.1 MERGERS & ACQUISITIONS
      • 7.1.2 PRODUCT LAUNCHES & DEVELOPMENTS
      • 7.1.3 PARTNERSHIPS & AGREEMENTS
      • 7.1.4 BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
    • 7.2 COMPANY PROFILES
      • 7.2.1 ALLERGAN PLC (ACQUIRED BY ABBVIE)
      • 7.2.2 ALMA LASERS LTD (ACQUIRED BY FOSUN PHARMA)
      • 7.2.3 BAUSCH HEALTH COMPANIES INC (FORMERLY VALEANT PHARMACEUTICALS)
      • 7.2.4 CANDELA CORP (FORMERLY SYNERON MEDICAL LTD)
      • 7.2.5 CUTERA INC
      • 7.2.6 CYNOSURE (ACQUIRED BY CLAYTON, DUBILIER & RICE)
      • 7.2.7 GALDERMA (ACQUIRED BY EQT)
      • 7.2.8 IPSEN SA
      • 7.2.9 JOHNSON & JOHNSON
      • 7.2.10 LUMENIS LTD
      • 7.2.11 MERZ PHARMA
      • 7.2.12 SIENTRA INC
      • 7.2.13 SINCLAIR PHARMA PLC
USD 1,600 or Partial Purchase
*Prices are subject to change by the publisher.
© 2026 ShareFair Inc.